| EPB0231 | Incidence and types of Adverse Drug Reactions to first-line antiretroviral therapy in Nigeria | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPE0803 | Incentivized peer referral to increase reach of pharmacy-delivered PrEP and PEP services: findings from a pilot study extension | E-poster | Implementation science and scale up of prevention |
| OAA0203 | In vivo genome engineering of human T cells results in ART-free control of HIV-1 in humanized mice | Oral abstract session with live Q&A | Novel treatment and prevention strategies |
| MOPEE28 | Improving viral load suppression among children aged 0-14 years through community ART distribution in rural Uganda: lessons from Anyeke HCIV | Poster exhibition | Implementation science and scale up of treatment |
| EPC0492 | Improving viral load coverage and sustaining high viral load suppression amidst operational challenges in Burundi | E-poster | Cascades of HIV care and treatment |
| EPB0194 | Improving the safety of clients on antiretroviral therapy through Drug Use Evaluations (DUE) to manage adverse drug events at six ART sites in the Oromia region of Ethiopia | E-poster | Clinical complications of HIV and antiretroviral therapy |
| EPE1002 | Improving the precision of subnational AGYW risk estimates in South Africa and Côte d’Ivoire | E-poster | Innovations in data collection, monitoring and evaluation |
| EPB0123 | Improving the diagnosis of HIV in hospitalized infants: lessons learned from the EMPIRICAL trial | E-poster | Diagnostic and monitoring tools |
| EPC0508 | Improving retention in ART care through client experience: a snapshot from Petauke District Hospital, Zambia | E-poster | Cascades of HIV care and treatment |
| EPE0843 | Improving multi-month dispensing of antiretroviral therapy at the Mulago most at risk populations initiative clinic, Uganda | E-poster | Implementation science and scale up of treatment |